Nitrodopamine modified MnO2 NS-MoS2QDs hybrid nanocomposite for the extracellular and intracellular detection of glutathione

We have developed a highly sensitive and reliable fluorescence resonance energy transfer (FRET) probe using nitro-dopamine (ND) and dopamine (DA) coated MnO2 nanosheet (ND@MnO2 NS and DA@MnO2 NS) as an energy acceptor and MoS2 quantum dots (QDs) as an energy donor. By employing surface-modified MnO2 NS, we can effectively reduce the fluorescence intensity of MoS2 QDs through FRET. It can reduce MnO2 NS to Mn2+ and facilitate the fluorescence recovery of the MoS2 QDs. This ND@MnO2 NS@MoS2 QD-based nanoprobe demonstrates excellent sensitivity to GSH, achieving an LOD of 22.7 nM in an aqueous medium while exhibiting minimal cytotoxicity and good biocompatibility. Moreover, our sensing platform shows high selectivity to GSH towards various common biomolecules and electrolytes. Confocal fluorescence imaging revealed that the nanoprobe can image GSH in A549 cells. Interestingly, the ND@MnO2 NS nanoprobe demonstrates no cytotoxicity in living cancer cells, even at concentrations up to 100 μg mL-1. Moreover, the easy fabrication and eco-friendliness of ND@MnO2 NS make it a rapid and simple method for detecting GSH. We envision the developed nanoprobe as an incredible platform for real-time monitoring of GSH levels in both extracellular and intracellular mediums, proving valuable for biomedical research and clinical diagnostics.

Functionalized nanozyme with drug loading for enhanced tumour combination treatment of catalytic therapy and chemotherapy

Nanozyme-based tumour catalytic therapy has attracted widespread attention in recent years, but the therapeutic efficacy is limited due to the trapping of hydroxyl radicals (˙OH) by endogenous glutathione (GSH) in the tumour microenvironment (TME). Zr/Ce-MOFs/DOX/MnO2 is constructed in this work to serve as a new kind of nanozyme for combination chemotherapy and catalytic treatment. Zr/Ce-MOFs can produce ˙OH in a mimic TME, and the MnO2 on the surface could deplete the GSH, further promoting the ˙OH generation. The pH/GSH dual stimulation accelerates the release of anticancer drug doxorubicin (DOX) in tumour tissue for enhanced tumour chemotherapy. Moreover, Mn2+ produced by the reaction of Zr/Ce-MOFs/DOX/MnO2 and GSH can be used as the contrast agent for T1-MRI. The potential antitumour effect of Zr/Ce-MOFs/DOX/MnO2 is demonstrated by in vitro and in vivo cancer treatment tests. This work thus provides a new nanozyme-based platform for enhanced combination chemotherapy and catalytic treatment for tumours.

Smartphone-assisted ratiometric fluorescence sensing platform and logical device based on polydopamine nanoparticles and carbonized polymer dots for visual and point-of-care testing of glutathione

As a crucial biothiol, glutathione (GSH) plays a key role in the organisms. Monitoring GSH level is of great significance for disease diagnosis and biomedical research. In this work, polydopamine (PDA) nanoparticles-red fluorescent carbonized polymer dots (r-CPDs) based ratiometric fluorescence sensing platform was constructed and employed for GSH assay. Dopamine (DA) could be oxidized by cobalt oxyhydroxide (CoOOH) nanosheets and further polymerized into PDA nanoparticles with green fluorescence. However, in the presence of GSH, CoOOH nanosheets were reduced and decomposed, which prevented the production of PDA nanoparticles. In the sensing system, green-emitting PDA nanoparticles were employed as a response unit and r-CPDs were used as an internal reference unit. With the addition of GSH, the green fluorescence of PDA nanoparticles decreased as well as the red fluorescence of system remained relatively stable. Importantly, a distinct fluorescence color evolution from green to red was presented with a serious of GSH concentrations. Based on this, a portable smartphone-assisted ratiometric chromaticity analytical method was developed to achieve the on-site visual detection of GSH. Both the established ratiometric fluorescence and ratiometric chromaticity sensing methods for GSH assay have the merits of wide linear range, high sensitivity and excellent accuracy, which are suitable for the determination of GSH in human serum and exhibit great application potential in rapid and accurate monitoring of the GSH levels in clinical. Moreover, an ingenious logical device reflecting GSH levels was designed based on the two different fluorescence signals, which provided a new strategy for the intelligent online detection of GSH in complex biological matrices.